These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 30545499

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hepatic embolotherapy in interventional oncology: technology, techniques, and applications.
    Kritzinger J, Klass D, Ho S, Lim H, Buczkowski A, Yoshida E, Liu D.
    Clin Radiol; 2013 Jan; 68(1):1-15. PubMed ID: 22917735
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
    Fidelman N, Kerlan RK.
    AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Arterial Changes Due to Chemoembolization of Hepatocellular Carcinoma Impacting Subsequent Radioembolization.
    Patel P, Charles HW, Park J, Deipolyi AR.
    J Vasc Interv Radiol; 2016 Sep; 27(9):1451-1453. PubMed ID: 27566429
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pretransplant Intra-arterial Liver-Directed Therapy Does Not Increase the Risk of Hepatic Arterial Complications in Liver Transplantation: A Single-Center 10-Year Experience.
    Kallini JR, Gabr A, Ali R, Abouchaleh N, Riaz A, Baker T, Kulik L, Caicedo J, Salem R, Lewandowski RJ.
    Cardiovasc Intervent Radiol; 2018 Feb; 41(2):231-238. PubMed ID: 28900709
    [Abstract] [Full Text] [Related]

  • 13. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.
    Kallini JR, Gabr A, Salem R, Lewandowski RJ.
    Adv Ther; 2016 May; 33(5):699-714. PubMed ID: 27039186
    [Abstract] [Full Text] [Related]

  • 14. Transcatheter intraarterial therapies: rationale and overview.
    Lewandowski RJ, Geschwind JF, Liapi E, Salem R.
    Radiology; 2011 Jun; 259(3):641-57. PubMed ID: 21602502
    [Abstract] [Full Text] [Related]

  • 15. Technical aspects of radioembolization with 90Y microspheres.
    Salem R, Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Ibrahim S, Nemcek AA, Omary RA, Madoff DC, Murthy R.
    Tech Vasc Interv Radiol; 2007 Mar; 10(1):12-29. PubMed ID: 17980315
    [Abstract] [Full Text] [Related]

  • 16. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).
    Hoffmann RT, Paprottka P, Jakobs TF, Trumm CG, Reiser MF.
    Abdom Imaging; 2011 Dec; 36(6):671-6. PubMed ID: 21584635
    [Abstract] [Full Text] [Related]

  • 17. 90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness.
    Xing M, Kokabi N, Camacho JC, Kooby DA, El-Rayes BF, Kim HS.
    J Comp Eff Res; 2013 Jul; 2(4):435-44. PubMed ID: 24236684
    [Abstract] [Full Text] [Related]

  • 18. Standards of practice in transarterial radioembolization.
    Mahnken AH, Spreafico C, Maleux G, Helmberger T, Jakobs TF.
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):613-22. PubMed ID: 23511991
    [No Abstract] [Full Text] [Related]

  • 19. Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver.
    Kvols LK, Turaga KK, Strosberg J, Choi J.
    J Natl Compr Canc Netw; 2009 Jul; 7(7):765-72. PubMed ID: 19635229
    [Abstract] [Full Text] [Related]

  • 20. Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy.
    Kennedy AS, Brown DB, Fakih M, Jeyarajah R, Jones S, Liu D, Pinato DJ, Sangro B, Sharma NK, Sze DY, Van Cutsem E, Wasan HS.
    J Vasc Interv Radiol; 2024 Sep; 35(9):1253-1267.e1. PubMed ID: 38885899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.